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Background In Caucasian populations, adult height is inversely associated with
cardiovascular disease (CVD) risk and positively related to some
cancers. However, there are few data from Asian populations and
from women. We sought to determine the sex- and region-specific
associations between height and cardiovascular outcomes, and
deaths due to cancer, respiratory and injury in populations from
the Asia-Pacific region.
Methods Thirty-nine studies from the Asia Pacific Cohort Studies
Collaboration database were included. We used Cox proportional
hazard regression models to estimate the associations between
height and pre-specified outcomes.
Results A total of 510 800 participants with 21 623 deaths were included.
Amongst men, inverse linear associations were observed between
height and coronary heart disease (CHD), stroke, CVD, injury and
total mortality. The hazard ratios [95% confidence intervals, (CI)]
for a 1-SD (¼ 6 cm) increment in height ranged from 0.85 (0.80–
0.91) for injury to 0.97 (0.95–0.98) for total mortality. Similar
trends were found between height and CHD, haemorrhagic stroke
and CVD in women. A positive linear association was observed
between height and cancer mortality. For each standard deviation
greater height, the risk of cancer was increased by 5% (2–8%) and
9% (5–14%) in men and women, respectively. No regional differ-
ence was observed between Asian and Australasian cohorts.
Adjusting for markers of education did not alter the results.
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Conclusions The opposing relationships of height with CVD and cancer suggest
that care is required in setting national policies on childhood nutri-
tion lest they have unintended consequences on the incidence of
major non-communicable diseases.
Keywords Body height, cardiovascular disease, cancer, respiratory disease,
injury, mortality
Introduction
Findings from observational studies indicate that
impaired fetal growth1 and psychosocial stress,
sub-optimal nutrition and socioeconomic disadvant-
age2 during childhood are linked with short adult
stature. Adult stature itself has been reported to be
negatively associated with coronary heart disease
(CHD) and stroke, with some studies suggesting a
10-cm increment in height to be associated with an
12–25% reduction in risk of CHD and 20–24% reduc-
tion in risk of stroke.3–5 In some studies, statistical
evidence is lost, particularly after adjustment for
age and socio-economic status.6–8 In contrast, height
is reported to be positively associated with risk of
cancer, with 20–60% higher risk of certain cancers
for taller persons.9 Further, in other populations,
there is some suggestion of a sex differential in the
reported association between height and mortality,
although to what extent this is a reflection of insuffi-
cient statistical power rather than any real gender
difference is unknown.10,11 If real, these opposing
relationships could provide insights regarding aetio-
logical pathways for cancer and cardiovascular disease
(CVD).
A major limitation of these earlier analyses is the
lack of representativeness of the study populations
since most of the data were derived from Caucasians,
with comparatively few data from Asian populations,
in whom the relationships between body stature
with health outcomes have been inconsistently
reported.12–14 By pooling data from a series of
cohort studies from the Asia-Pacific region, we quan-
tify the relationships between height with a range of
morbidity and mortality outcomes, from chronic dis-
ease to external causes, to clarify the pattern of these
associations. Presenting the associations between
height and a range of mortality and morbidity out-
comes, rather than a disease single outcome, pro-
vides improved insights into aetiology of particular
diseases.15
Methods
The Asia Pacific Cohort Studies Collaboration
(APCSC) is a large collaborative project consisting of
over 600 000 participants from 44 cohort studies in
the Asia-Pacific region. Details of the collaboration
have been published elsewhere.16 Briefly, studies were
eligible for inclusion if they met the following criteria:
(i) a study population from the Asia Pacific region;
(ii) prospective cohort study design; (iii) at least 5000
person-years of follow-up; (iv) date of birth (or age),
sex and blood pressure recorded at baseline; and
(v) date of death or age at death recorded during
follow-up. In this study, only those participants with
baseline data on age, year of birth, sex, height, systolic
blood pressure (SBP), smoking and fatal or non-fatal
outcomes were included in analyses.
Disease outcomes
Outcomes were classified according to the ninth revi-
sion of the International Classification of Diseases
(ICD-9): CHD (ICD-9, 410–414), stroke (ICD-9,
430–438), haemorrhagic stroke (ICD-9, 431.0–432.9),
ischaemic stroke (ICD-9, 433.0–434.9), cancer (ICD-9,
140–208), respiratory disease (ICD-9, 010–019, 136.6,
137, 460–467, 479–519) and injury (ICD-9, 800–999).
All studies recorded deaths. Of the 39 studies
included in this analysis, 18 studies additionally
reported non-fatal stroke, and 15 reported non-fatal
CHD outcomes. Cardiovascular events were defined as
fatal CVD, non-fatal myocardial infarction and non-
fatal stroke; no non-fatal outcomes were recorded for
cancer, respiratory disease or injury.
Statistical analyses
Separately for men and women, associations between
height and each of the outcomes were obtained from
Cox regression models with adjustment for age, year
of birth and study. We computed hazard ratios (HRs)
for height in four equal groups (sex-specific fourths)
with 95% confidence intervals (CIs) obtained from
floating absolute risks, and as continuous variables,
obtaining the HR for a standard deviation (SD)
increase. Subgroup analyses estimated the separate
effects by region [Asia and Australasia (Australia
and New Zealand)]. Sensitivity analysis by age
group estimated the effect of possible shrinkage in
stature with age. Participants were divided into age
<60 years and 560 years at baseline to form approxi-
mately equal numbers per group. We tested for effect
modification of age or region by adding an interaction
term between height and age and between height and
region to the Cox model, whilst a test for linear trend
involved fitting a Cox model with an ordinal variable
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defined by the fourths of height. In addition, non-
linearity on the height–outcome relationships were
also tested by comparing, using a likelihood ratio
chi-square, the Cox model fitting the four height
groups as a categorical variable with the Cox model
fitting the height groups as an ordinal variable. The
analyses were repeated with further adjustments
made for SBP and cigarette smoking. Results were
also adjusted for total cholesterol (TC) in a subgroup
analysis of those studies with data for this variable.
Given that stature is socioeconomically patterned, we
also controlled for education, which was available in
selected studies. Educational attainment levels were
classified into three groups [none/not completed pri-
mary, completed primary (age 10 years), completed
secondary (age 17/18 years) or completed tertiary].
All analyses were based on data from individual par-
ticipants aged 520 years at the time of the baseline
survey. All statistical analyses were performed using
SAS 9.1 for Windows (SAS Institute Inc., USA).
Results
A total of 510 800 participants (81% Asian; 35%
female) comprised the analytical sample. At baseline,
the mean (SD) age was 48 years (11 years) and the
mean (SD) height was 169 cm (6 cm) and 157 cm
(6 cm) in men and women, respectively (Table 1).
Compared with individuals from Asian cohorts,
those from Australasia were generally older, taller,
had higher mean SBP and TC, were less likely to
have reported being a smoker and more likely to
have completed tertiary education (24% Australasian
vs 13% Asian) at study baseline. During the 3 284 397
person-years of follow-up, there were 21 623 fatal
events and 9259 non-fatal events (for CHD and
stroke); 11 023 CVD, 7497 cancers, 5389 strokes
(37% ischaemic, 28% haemorrhagic, 6% subarachnoid
haemorrhages and 29% unknown subtype), 3933
CHD, 1597 respiratory and 1443 deaths due to
injury (Table 2). Subgroup analyses were performed
using 352 827 participants (69%; 76% Asian) with TC
values and 245 251 participants (48%; 65% Asian)
with data on educational attainment. Participants
from the Asian cohort were distributed evenly across
four height groups. In contrast, participants from the
Australasian cohort tended to be in the taller height
groups.
Height and risk of CHD
An inverse linear association between height and CHD
was observed for both sexes after allowing for age,
study and year of birth (Figure 1). Further adjust-
ment for SBP and smoking did not alter the associa-
tion (results available from authors on request). A
1-SD increase in height was associated with an 8%
(95% CI: 4–11%) decrease in subsequent CHD for
men. Evidence of such association was weak with a
4% (95% CI: 1 to 10%) decrease for women (Table 3).
No regional difference was observed for either sex
(P-value for interaction¼ 0.31 for men, P¼ 0.32 for
women). There was no difference in the strength of
the association between the two age groups for either
sex (Table 4). Further adjustment for TC or education
level did not materially alter the results (data not
shown).
Height and risk of stroke
For men, there was evidence of an inverse association
between height and risk of all strokes such that a
1-SD increment in height was associated with a 7%
(95% CI: 4–10%; Ptrend¼ 0.002) lower risk (Figure 1).
A similar association was observed for women [HR
0.94 (95% CI: 0.89–0.98)] but the evidence of a
trend across strata was weak (Ptrend¼ 0.11). In sub-
group analyses, height was inversely associated with
haemorrhagic stroke in women [HR 0.87 (95% CI:
0.79–0.96); Ptrend¼ 0.03]. No evidence of an associa-
tion between height and ischaemic stroke was
observed in either sex or between cohorts from Asia
and Australasia (Table 3). For each SD increase in
height, the reduction in risk of any stroke in
women aged <60 years and women aged 560 years
was 14 and 2%, respectively (Table 4; P-value for age
interaction¼ 0.01). For haemorrhagic stroke the cor-
responding reduction in risk was 25 and 3% (P-value
for age interaction¼ 0.008). Further adjustment for
TC or education level did not materially alter the
results (data not shown).
Height and risk of CVD
Consistent with CHD, an inverse linear association
between height and CVD was observed for both
sexes and the association persisted after adjustment
for age, study and year of birth (Figure 1). For each
1-SD increment in height, there was a 7% (95% CI:
5–9%) and 6% (95% CI: 3–9%) decrease in risk of CVD
for men and women, respectively (Table 3). As with
stroke, further adjustment for TC or education level
did not impact on the results (data not shown).
Height and cancer mortality
A positive linear association between height and mor-
tality from cancer was observed for both sexes after
adjustment for age, study and year of birth (Figure 1).
For men, a 1-SD increment in height was associated
with a 5% (95% CI: 2–8%) increase in mortality
from cancer (Table 3). For women, the respective
increase in risk was 9% (95% CI: 5–14%) with no
evidence to suggest regional heterogeneity in either
sex (Table 3). Compared with persons aged 560
years, the relationship between height and cancer
was weaker for younger persons (Table 4).
Adjustment for TC or education level did not alter
the results (data not shown).
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Height and injury mortality
An inverse linear association was observed between
height and risk of mortality from injury for men
(Ptrend < 0.001), but not for women (Ptrend¼ 0.79)
after adjusting for age, study and year of birth
(Figure 1). Additional adjustment for SBP and smok-
ing did not alter the results. For each 1-SD increase in
height, there was a 15% (95% CI: 9–20%) decrease in
injury mortality for men (Table 3). No evidence for
difference between regions or by age was observed for
either sex. Adjustment for TC or education level did
not alter the results.
Height and respiratory disease mortality
When respiratory disease was the outcome of interest,
there was no association with height in either men or
women in any analysis.
Height and risk of all-cause mortality
As with injury, an inverse linear association between
height and total mortality was observed for men
(Ptrend¼ 0.002) but not for women (Ptrend¼ 0.76)
(Figure 1). However, for each 1-SD increase in
height, the reduction in total mortality was similar
for both sexes (Psex¼ 0.5). Additional adjustment for
SBP and smoking did not alter the estimates. For
each 1-SD increase, there was a 3% (95% CI: 2–5%)
reduction in total mortality risk for men, with no
evidence of regional heterogeneity (Table 3). For
each 1-SD increment in height, men aged <60 years
had a 7% decrease risk for total mortality whereas no
change in risk was observed in men aged 560 years
(Table 4). Identical results were obtained when TC or
education level were included in the analyses.
Discussion
Our analysis of a group of prospective cohorts com-
prising data on more than 21 000 deaths and 9000
non-fatal cardiovascular events is several orders of
magnitude greater than previous studies that have
examined the relationships of adult height to chronic
disease endpoints. Hence, it should provide more reli-
able estimates of effect than any previous individual
study. Consistent with earlier observations, inverse
linear associations with height were apparent for
CHD and CVD in both sexes. However, consistent
with other studies, the associations were relatively
small in magnitude such that an 6 cm (1 SD) incre-
ment in height was associated with a 5–10% reduc-
tion in risk.17,18 In contrast, but again in agreement
with earlier reports, height was positively associated
with an increased risk of cancer, the association being
of the same size as that for CVD.19
While an inverse association between height and
CHD has been widely documented, reports of a rela-
tionship between height and risk of ischaemic stroke
have been inconsistent, with some studies observingT
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an inverse relationship4,14 and others (including the
current study with the exception of men in
Australasia) no relationship.6,17,20 Estimates from
our current analyses do support an inverse relation-
ship with haemorrhagic stroke, mainly due to the
strong association in the Asian cohort, which is
likely to at least partially account for the inverse
trend between height and total strokes reported
here. As there was no evidence of a difference in
the magnitude of this association between Asia and
Australasia, the relationships with height may be
related to other factors such as childhood and adult
socio-economic status. A Korean study showed a 2–5%
change in HRs for stroke and stroke sub-types after
adjusting for socio-economic indicators.12 Impor-
tantly, there was no evidence of marked attenuation
when we included education level as a socio-economic
indicator in our multivariable models.
Few studies have reported on association between
height and mortality from all cancers combined,
Figure 1 Age, study and year of birth adjusted HRs (95% CIs) for each outcome by height quarters in all participants.
Black boxes represent male and white boxes represent female. P-values are test of linear trend by sex
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Table 4 Age, study and year of birth adjusted HR (95% CIs) per 1-SD increase in height stratified by age group
Outcome Sex No. of events Overall Age <60 years Age 560 years
P-value for
interaction
Coronary heart disease M 2780 0.92 (0.89–0.96) 0.92 (0.87–0.97) 0.93 (0.88–0.97) 0.76
F 1153 0.96 (0.90–1.01) 0.97 (0.88–1.08) 0.94 (0.87–1.00) 0.52
Stroke M 3473 0.93 (0.90–0.96) 0.90 (0.86–0.95) 0.96 (0.92–1.01) 0.07
F 1916 0.94 (0.89–0.98) 0.86 (0.80–0.93) 0.98 (0.93–1.04) 0.01
Haemorrhagic stroke M 1050 0.91 (0.85–0.96) 0.87 (0.80–0.95) 0.96 (0.87–1.05) 0.16
F 484 0.87 (0.79–0.96) 0.75 (0.66–0.87) 0.97 (0.85–1.09) <0.01
Ischaemic stroke M 1334 0.95 (0.90–1.01) 0.93 (0.86–1.00) 0.98 (0.90–1.07) 0.31
F 649 0.98 (0.90–1.06) 0.95 (0.84–1.08) 1.00 (0.90–1.11) 0.53
Cardiovascular disease M 7293 0.93 (0.91–0.95) 0.91 (0.88–0.94) 0.95 (0.92–0.98) 0.06
F 3730 0.94 (0.91–0.97) 0.90 (0.85–0.95) 0.96 (0.92–1.00) 0.06
All-cancer mortality M 5232 1.05 (1.02–1.08) 0.99 (0.96–1.03) 1.11 (1.06–1.15) <0.01
F 2265 1.09 (1.05–1.14) 1.10 (1.04–1.17) 1.08 (1.02–1.15) 0.65
Respiratory disease M 1038 0.95 (0.90–1.01) 0.95 (0.85–1.07) 0.96 (0.90–1.02) 0.94
F 559 0.93 (0.86–1.01) 0.94 (0.78–1.14) 0.93 (0.85–1.01) 0.89
Injury M 1086 0.85 (0.80–0.91) 0.85 (0.79–0.91) 0.88 (0.77–1.01) 0.63
F 357 0.98 (0.88–1.10) 0.97 (0.84–1.13) 1.07 (0.90–1.27) 0.39
Total mortality M 14628 0.97 (0.95–0.98) 0.93 (0.91–0.96) 1.00 (0.98–1.02) <0.01
F 6995 0.98 (0.96–1.01) 1.01 (0.97–1.05) 0.97 (0.94–1.00) 0.14
Table 3 Age, study and year of birth adjusted HR (95% CIs) per 1-SD increase in height stratified by region
Outcome Sex No. of events Overalla Australasia Asia
P-value for
interaction
Coronary heart disease M 2780 0.92 (0.89–0.96) 0.91 (0.88–0.95) 0.95 (0.89–1.01) 0.31
F 1153 0.96 (0.90–1.01) 0.94 (0.87–1.00) 1.00 (0.90–1.10) 0.32
Stroke M 3473 0.93 (0.90–0.96) 0.93 (0.87–0.98) 0.93 (0.90–0.97) 0.82
F 1916 0.94 (0.89–0.98) 0.95 (0.88–1.03) 0.93 (0.88–0.98) 0.56
Haemorrhagic stroke M 1050 0.91 (0.85–0.96) 0.95 (0.80–1.11) 0.90 (0.84–0.96) 0.58
F 484 0.87 (0.79–0.96) 0.95 (0.77–1.19) 0.86 (0.78–0.95) 0.38
Ischaemic stroke M 1334 0.95 (0.90–1.01) 0.88 (0.79–0.98) 0.98 (0.92–1.04) 0.10
F 649 0.98 (0.90–1.06) 0.98 (0.84–1.15) 0.98 (0.89–1.07) 0.95
Cardiovascular disease M 7293 0.93 (0.91–0.95) 0.93 (0.90–0.96) 0.93 (0.91–0.96) 0.88
F 3730 0.94 (0.91–0.97) 0.95 (0.90–0.99) 0.94 (0.90–0.98) 0.85
All-cancer mortality M 5232 1.05 (1.02–1.08) 1.06 (1.02–1.10) 1.04 (1.00–1.08) 0.41
F 2265 1.09 (1.05–1.14) 1.11 (1.05–1.17) 1.08 (1.01–1.14) 0.47
Respiratory disease M 1038 0.95 (0.90–1.01) 0.92 (0.84–1.00) 0.98 (0.91–1.06) 0.27
F 559 0.93 (0.86–1.01) 0.96 (0.84–1.10) 0.92 (0.83–1.01) 0.58
Injury M 1086 0.85 (0.80–0.91) 0.94 (0.84–1.07) 0.82 (0.77–0.88) 0.06
F 357 0.98 (0.88–1.10) 1.05 (0.88–1.26) 0.95 (0.83–1.09) 0.35
Total mortality M 14 628 0.97 (0.95–0.98) 0.97 (0.95–0.99) 0.96 (0.94–0.98) 0.64
F 6995 0.98 (0.96–1.01) 0.99 (0.95–1.02) 0.98 (0.95–1.01) 0.78
aIncluding SBP and smoking in the model did not alter the results.
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focusing instead on its relationship with specific can-
cers, but the findings have been conflicting. While
a Finnish study reported no association between
height and cancer for either sex,21 the Renfrew and
Paisley study reported a positive but weak association
between height and cancers not related to smoking.3
Similar to our finding, the age-adjusted relative
risk for cancer for men from the Whitehall study
was 1.03 (95% CI: 1.00–1.05) for each 5-cm increase
in height.19 The apparent lack of an association
between height and cancer for men aged <60 years
could be due to different cancer patterns. It has been
shown that the increased cancer risk in tall relative to
shorter people differs by cancer type ranging from
10 to 60%.9
Findings from the current study suggest an inverse
association between height and risk of fatal injury,
although the relationship was only observed for
men. This may be a chance finding due to the large
number of comparisons performed. However, it is
consistent with the results from a Swedish study22
that reported a 9% decrease in suicide risk for each
5-cm increase in height although not all studies have
observed such an association.23
The apparent opposing associations between CVD
and cancer for height might have resulted in the
lack of an association between height and total mor-
tality for women. The small inverse association
observed in our analysis between height and total
mortality in men might be influenced by the large
weighting of the KMIC study, which contributed
36% of the participants in the APCSC and that
KMIC participants were aged 35–59 years at baseline.
However, the association we observed remained evi-
dent in sensitivity analyses that tested the effects of
the KMIC study on the regional and age estimates.
Although adult height has been reported to be asso-
ciated with cardiorespiratory disease and certain types
of cancer, it is uncertain whether height is the causal
factor. Height is possibly a surrogate marker of
risk factors such as insulin-like growth factor (IGF)
levels. For example, case-control studies of CHD have
reported lower levels of IGF-I for cases.24,25 In regard
to cancer, attained height has been hypothesized to
increase risk because of the greater number of cells
available for malignant transformation.26 Height may
also usefully capture pre-adult environmental expo-
sures such as socio-economic position,27 nutrition
and possibly, psychosocial stress.28
There are limitations to this study. First, socio-
economic status, especially childhood socio-economic
status, has been shown to be positively associated
with adult height and negatively associated with car-
diovascular risks.29–32 The APCSC only had data on
education level to use in this study as an indicator
of socio-economic status. The higher percentage of
participants completing secondary education or
above in the Asian cohort might be due to selection
bias since some studies were based on occupational
cohorts. Nevertheless, other studies have shown
changes in estimates of cardiovascular risk of
<10% change after adjustment for socio-economic
status.5,12,33 Secondly, as intergenerational increase
in height is becoming more rapid in Asian countries
due to the recent nutrition transition in this region,
our results might have been confounded by birth
cohort effects. We have included year of birth in the
models and, given that 90% of members of our
cohorts were born between 1930 and 1960, any
effect caused by the intergenerational increase in
height should have been minimal. Thirdly, leg
length has been reported to be associated with CHD
and cancer.9,33 As Asians tend to have shorter legs
relative to body height than Caucasians, associations
between leg length and study outcome might differ
between Asians and Australasians. In any case, these
associations could not be investigated as data on leg
length were not available in the APCSC. Fourthly, we
did not compare the absolute risk for a particular level
of height between Asians and Australasians because,
a priori, background rates of many of the endpoints of
interest are very different. Further, as Asians are
rapidly catching up with Caucasians in height, the
difference in mean height between them will
become smaller over the next few decades. Fifthly,
physical activity and diet are potential confounders,
which were not included in the model due to the
lack of such data in APCSC.
Given that smoking, obesity and lack of physical
activity overlap as risk factors for both CVD and sev-
eral common cancers, the opposing relationships
between CVD and mortality from cancer reported
here underline the need for more research into the
aetiological pathways of major non-communicable
diseases as residual confounding may have resulted
from the lack of detailed data on socio-economic
status. Until this is done, policies such as those
intended to increase nutritional intake in children to
promote vertical growth cannot be recommended, lest
they contribute to the growing tide of obesity in the
Asia-Pacific region and around the world. Such
an unintended consequence would have important
adverse effects on the incidence of all of diabetes,
CVD and certain cancers.
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